new glp-1 drugs Eli Lilly to seek approval of weight-loss drug this year New Daily GLP-1 Weight Loss

2 Pharmacological characterization of GLP-1MK-801

Analysts say success could significantly expand the overall market for obesity treatment, while failure could leave the company vulnerable to competitors with more convenient or cheaper options

GLP-1-(9-36) amide reduces blood glucose in anesthetized pigs by a mechanism that does not involve insulin secretion

The GLP-1 hormone is released after eating

MEDVis site did not identify either physician as being affiliated with Ringside Health

Effect of exenatide use on cognitive and affective functioning in obese patients with type 2 diabetes mellitus: exenatide use mediates depressive scores through increased perceived stress levels